리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 274 Pages
라이선스 & 가격 (부가세 별도)
한글목차
헬스케어 콜드체인 물류 세계 시장은 2030년까지 238억 달러에 달할 것으로 전망
2023년 182억 달러로 추정되는 헬스케어 콜드체인 물류 세계 시장은 2023-2030년의 분석 기간 동안 연평균 3.9% 성장하여 2030년에는 238억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 백신은 CAGR 3.6%를 기록하여 분석 기간 종료 시점에 111억 달러에 도달할 것으로 예상됩니다. 임상시험 재료 부문의 성장률은 분석 기간 동안 CAGR 4.1%로 추정됩니다.
미국 시장은 48억 달러로 추정, 중국은 CAGR 6.0%로 성장 전망
미국 헬스케어 콜드체인 물류 시장은 2023년 48억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년 연평균 6.0%의 성장률로 2030년까지 50억 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 2.6%와 3.1%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 3.0%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
세계 헬스케어 콜드체인 물류 시장 - 주요 동향 및 촉진요인 요약
헬스케어 콜드체인 물류가 온도 변화에 민감한 제품의 무결성을 유지하고 환자의 안전을 보장하는 데 필수적인 이유는 무엇일까요?
헬스케어 콜드체인 물류는 백신, 생물학적 제제, 의약품 등 온도에 민감한 의료 제품의 무결성을 유지하고 환자의 안전을 보장하는 데 필수적입니다. 그렇다면 오늘날 헬스케어 콜드체인 물류가 왜 이토록 중요한 것일까? 많은 의료 제품, 특히 백신, 혈액제제, 유전자 치료 관련 제품은 온도 변화에 매우 민감합니다. 필요한 보관 조건에서 벗어나면 제품의 효능이 떨어지거나 사용하기에 적합하지 않게 되거나 부패할 수 있습니다. 이러한 제품이 환자에게 효과적이고 안전한 상태로 유지되기 위해서는 제조 시설에서 투약 시점까지 공급망 전체에 걸쳐 적절한 온도를 유지하는 것이 매우 중요합니다.
헬스케어 콜드체인 물류에는 의료 제품이 특정 온도 범위 내에서 보관 및 유통될 수 있도록 하는 특수 공정, 포장, 모니터링 및 운송 솔루션이 포함됩니다. 이 콜드체인은 많은 생명을 구하는 제품, 특히 예방 접종, 암 치료 및 기타 첨단 의료에 사용되는 제품의 안정성과 효능을 유지하는 데 필요합니다. 생물학적 제제, 맞춤형 의약품 및 백신에 대한 수요가 증가함에 따라 콜드체인 물류는 헬스케어 산업에서 점점 더 중요해지고 있으며, 환자가 의도한 대로 치료 효과가 있는 제품을 받을 수 있도록 돕고 있습니다.
기술의 발전과 혁신은 헬스케어 콜드체인 물류의 효율성, 정확성 및 모니터링을 어떻게 개선하고 있는가?
기술의 발전으로 헬스케어 콜드체인 물류의 효율성, 정확성 및 모니터링이 크게 향상되어 온도에 민감한 의료 제품의 운송 및 보관 관리가 쉬워졌습니다. 가장 영향력 있는 기술 혁신 중 하나는 실시간 온도 모니터링 시스템의 사용입니다. 이 시스템은 센서, GPS 및 무선 통신을 사용하여 공급망 전체에서 의료 제품의 온도를 지속적으로 추적합니다. 제품이 필요한 범위를 벗어난 온도에 노출되면 시스템은 즉시 경고를 보내 제품 열화를 방지하기 위해 신속한 시정 조치를 취할 수 있도록 합니다. 이러한 실시간 가시성은 콜드체인 물류의 신뢰성을 향상시키고 제품 손실의 위험을 줄여줍니다.
또 다른 주요 발전은 특정 온도 범위를 장기간 유지하도록 설계된 스마트 패키징 솔루션의 개발입니다. 이러한 패키징 솔루션은 온도 변화로부터 제품을 보호하기 위해 상변화물질, 진공 단열 패널 및 기타 첨단 재료를 통합하는 경우가 많습니다. 일부 스마트 패키지에는 온도 데이터를 모니터링하고 기록하는 데이터 로거가 장착되어 있어 제품이 운송 중 필요한 조건 내에서 유지되고 있음을 검증 가능한 형태로 증명할 수 있습니다. 헬스케어 제품은 안전성과 유효성을 보장하기 위해 엄격한 온도 관리 가이드라인을 충족해야 하기 때문에 규제 준수를 위해 특히 중요한 부분입니다.
블록체인 기술 또한 헬스케어 콜드체인 물류의 투명성과 안전성을 향상시키는 혁신적인 도구로 부상하고 있습니다. 블록체인은 공급망을 통한 제품의 모든 거래와 이동을 기록하는 분산형 위변조 방지 원장을 생성할 수 있게 해줍니다. 이 기술을 통해 공급망에 참여하는 모든 당사자(제조업체, 유통업체, 물류업체, 의료 시설)가 제품의 온도 이력, 위치, 취급에 대한 정확한 정보를 동일하게 확인할 수 있습니다. 블록체인의 투명성은 부정행위의 위험을 줄이고, 규제 준수를 보장하며, 온도에 민감한 제품에 검증 가능한 Chain of Custody를 제공함으로써 이해관계자간의 신뢰를 향상시킬 수 있습니다.
인공지능(AI)과 머신러닝(ML)도 콜드체인 물류 최적화에 중요한 역할을 하고 있으며, AI 기반 시스템은 온도 관리, 운송 경로, 보관과 관련된 방대한 양의 데이터를 분석하여 비효율성을 파악하고 잠재적인 문제를 예측할 수 있습니다. 예측할 수 있습니다. 예를 들어, AI는 콜드체인에 영향을 미칠 수 있는 날씨, 교통 지연, 장비 고장을 예측하고 위험을 줄이기 위한 대체 경로와 솔루션을 추천할 수 있습니다. 머신러닝 알고리즘은 과거 데이터로부터 학습을 통해 이러한 예측의 정확도를 지속적으로 향상시켜 물류 제공업체가 보다 현명한 의사결정을 내리고 콜드체인 프로세스의 신뢰성을 높일 수 있도록 돕습니다.
콜드체인 물류에 사물인터넷(IoT) 기기를 도입하는 것도 중요한 혁신으로, 운송 컨테이너, 트럭 및 보관 시설에 IoT 지원 센서를 설치하여 온도, 습도 및 기타 환경적 요인을 실시간으로 모니터링할 수 있습니다. 이러한 장치를 통해 의료 서비스 제공업체는 제품의 상태를 지속적으로 파악할 수 있고, 중요한 의약품, 백신, 생물학적 샘플이 적절한 온도 범위 내에서 보관되고 있는지 확인할 수 있습니다. 또한, IoT 솔루션은 냉장 장비의 예지보전을 통해 장비 고장 위험을 줄이고, 공급망 전반에 걸쳐 제품 안전을 보장할 수 있습니다.
보건의료 콜드체인 물류가 제품의 유효성을 유지하고 폐기물을 줄이며 규제 요건을 충족하는 데 필수적인 이유는 무엇일까?
헬스케어 콜드체인 물류는 제품의 유효성을 유지하고, 폐기물을 줄이고, 규제 요건을 충족하는 데 필수적입니다. 온도에 민감한 의료 제품을 최적의 상태로 보관 및 운송할 수 있기 때문입니다. 콜드체인 물류의 가치가 높은 주요 이유 중 하나는 의약품, 백신 및 생물학적 제제의 효능을 유지하는 역할입니다. 예를 들어, 백신은 특정 온도에서 보관하지 않으면 효과가 지속되지 않습니다. 권장 온도 범위를 벗어난 온도에 노출되면 효능이 상실되어 환자가 효과가 없는 치료를 받을 위험이 있습니다. 콜드체인 물류는 이러한 제품들이 제조부터 투여까지 치료적 무결성을 유지할 수 있도록 보장합니다.
낭비를 줄이는 것도 헬스케어 콜드체인 물류의 중요한 장점입니다. 온도에 민감한 제품을 부적절하게 취급하거나 보관하면 제품 부패로 인해 막대한 금전적 손실이 발생할 수 있습니다. 경우에 따라 백신이나 생물학적 제제가 온도 편차에 노출되었습니다는 증거가 있는 경우, 전체 배송을 폐기해야 하는 경우도 있습니다. 효과적인 콜드체인 관리는 실시간 모니터링, 예측 분석, 자동화된 경고를 통해 일탈 발생 시 즉각적인 시정 조치를 취할 수 있는 자동화된 경고를 제공함으로써 이러한 사고의 위험을 최소화할 수 있습니다. 이를 통해 제품 낭비를 줄이고, 의료 기관은 귀중한 의료 제품 손실로 인한 재정적, 경영적 영향을 피할 수 있습니다.
콜드체인 물류는 규제 요건을 충족하기 위해서도 필수적입니다. 미국 식품의약국(FDA), 유럽의약품청(EMA), 세계보건기구(WHO)와 같은 규제 기관은 온도에 민감한 의료 제품의 취급, 보관 및 운송에 대한 엄격한 가이드라인을 규정하고 있습니다. 이러한 규정은 의료 서비스 제공업체가 제품의 안전성과 유효성을 유지하기 위한 모범 사례를 준수하도록 보장합니다. 이러한 규정을 준수하지 않을 경우, 벌금, 처벌 및 제품 회수의 대상이 될 수 있습니다. 온도 모니터링 및 데이터 로깅 기술이 적용된 콜드체인 물류 시스템은 공급망 전반의 온도 관리에 대한 검증 가능한 기록을 제공함으로써 의료 기관이 이러한 규제 요건을 충족하는 데 도움이 될 수 있습니다. 이러한 기록은 국내 및 국제 표준 준수를 증명하기 위한 감사 및 검사에서 요구되는 경우가 많습니다.
헬스케어 콜드체인 물류는 환자의 안전을 보장하는 데에도 중요한 역할을 합니다. 온도에 민감한 제품의 무결성이 손상되면 환자는 최적이 아니거나 안전하지 않은 치료에 노출될 수 있습니다. 예를 들어, 변질된 백신은 감염으로부터 환자를 보호할 수 없으며, 변질된 생물학적 제제는 부작용이나 비효율적인 치료로 이어질 수 있습니다. 콜드체인 물류 시스템은 온도 조건을 엄격하게 관리함으로써 이러한 위험으로부터 환자를 보호하고, 안전 기준을 충족하는 고품질의 효과적인 치료를 받을 수 있도록 합니다. 이는 생물학적 제제나 유전자 치료제가 환자 치료에 필수적이고 세심한 주의를 기울여야 하는 암 치료와 같은 분야에서 특히 중요합니다.
콜드체인 물류의 또 다른 장점은 특히 오지나 의료 서비스가 부족한 지역에서 세계 헬스케어 활동을 지원할 수 있다는 점입니다. 생명을 구하는 백신과 의약품의 대부분은 의료 인프라가 부족한 지역으로 전달하기 위해 장거리 운송이 필요합니다. 콜드체인 물류는 이러한 제품들이 변질되지 않고 안전하게 목적지에 도착하여 의료진이 효과적으로 투여할 수 있도록 보장합니다. 이는 전 세계 예방접종 캠페인과 공중보건 비상사태 대응에 있어 콜드체인 유지가 성공적인 의료 개입을 위해 필수적인 상황에서 특히 중요합니다.
헬스케어 콜드체인 물류 시장의 성장을 가속하는 요인은 무엇일까?
헬스케어 콜드체인 물류 시장의 급격한 성장에는 생물학적 제제 및 맞춤형 의약품에 대한 수요 증가, 세계 백신 캠페인 증가, 콜드체인 기술의 발전, 신흥 시장으로의 의약품 공급망 확대 등 몇 가지 중요한 요인이 있습니다. 주요 촉진요인 중 하나는 온도 변화에 매우 민감하고 정확한 보관 조건이 필요한 생물학적 제제 및 맞춤형 의약품에 대한 수요 증가입니다. 단클론 항체, 세포치료제, 유전자 치료제와 같은 생물학적 제제는 신약 승인에서 상당한 부분을 차지하고 있으며, 그 사용량은 계속 증가할 것으로 예상됩니다. 이러한 제품을 운송 및 보관하기 위한 전문 콜드체인 물류의 필요성이 시장 성장을 견인하고 있습니다.
세계 백신 접종 캠페인 증가도 헬스케어 콜드체인 물류의 확장에 기여하는 주요 요인으로, 코로나19 팬데믹은 전 세계적으로 백신을 배포하는 데 있어 효율적이고 신뢰할 수 있는 콜드체인의 중요성을 부각시켰습니다. 를 포함한 많은 코로나19 백신은 초저온 보관이 필요하기 때문에 안전한 유통을 위해서는 콜드체인 물류가 필수적입니다. 전 세계 보건 기관과 정부가 대규모 백신 접종 캠페인을 계속 진행함에 따라, 백신의 안전한 운송을 보장할 수 있는 콜드체인 물류 솔루션에 대한 수요가 증가할 것으로 예상됩니다.
실시간 모니터링 시스템, 스마트 패키징, IoT 지원 센서 등 콜드체인 기술의 발전도 시장 성장을 견인하고 있습니다. 이러한 기술 혁신을 통해 의료 서비스 제공업체는 공급망 전반에 걸쳐 온도에 민감한 제품을 쉽게 추적하고 유지할 수 있습니다. 실시간 데이터 로깅 및 경고를 통해 조직은 운송 및 보관 중 발생하는 문제에 신속하게 대응하고 제품 부패 위험을 줄일 수 있습니다. 이러한 첨단 기술의 도입이 증가함에 따라 콜드체인 물류의 효율성과 신뢰성이 향상되어 제약 및 의료 기관에 점점 더 매력적인 솔루션이 되고 있습니다.
신흥 시장으로의 의약품 공급망 확대도 헬스케어 콜드체인 물류 분야의 성장을 가속하는 중요한 요인입니다. 제약회사들은 신흥 시장 개척을 위해 온도에 민감한 제품을 장거리로 운송해야 하는 어려움에 직면해 있으며, 인프라가 부족한 지역을 경유하는 경우가 많습니다. 콜드체인 물류 제공업체들은 이러한 제품이 품질과 안전성을 훼손하지 않고 목적지까지 도달할 수 있도록 네트워크와 역량을 확장하고 있습니다. 제약회사들이 신흥 시장에서 계속 성장함에 따라 복잡한 국제 물류 환경에 대응할 수 있는 콜드체인 솔루션에 대한 수요가 증가할 것으로 예상됩니다.
규제 압력도 헬스케어 콜드체인 물류 시장의 성장에 기여하고 있습니다. 전 세계 규제 당국이 온도 변화에 민감한 제품의 보관 및 운송에 대한 가이드라인을 강화함에 따라, 헬스케어 기업들은 이러한 까다로운 요건을 충족할 수 있는 콜드체인 시스템에 투자해야 합니다. 규제 준수는 환자의 안전을 보장할 뿐만 아니라 벌금, 처벌, 제품 리콜을 피하기 위해서도 필수적입니다. 진화하는 규제 준수에 대한 필요성으로 인해 의료 서비스 제공업체와 제약사들은 보다 진보되고 신뢰할 수 있는 콜드체인 물류 솔루션을 도입하고 있습니다.
결론적으로, 헬스케어 콜드체인 물류 시장의 성장은 생물학적 제제에 대한 수요 증가, 세계 백신 접종 캠페인, 콜드체인 기술의 발전, 신흥 시장으로의 의약품 공급망 확장이 원동력이 되고 있습니다. 의료기관이 온도 변화에 민감한 제품의 무결성을 유지해야 하는 과제에 직면한 가운데, 콜드체인 물류는 제품의 안전성, 규제 준수 및 효과적인 환자 치료를 보장하는 데 필수적인 역할을 할 것입니다.
조사 대상 기업 예시(주목받는 44개사)
American Airlines, Inc.
AmerisourceBergen Corporation
Cavalier Logistics
Continental Carbon Company
DB Schenker
DHL International GmbH
FedEx Corporation
Kuehne Nagel International AG
Marken Ltd.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Healthcare Cold Chain Logistics Market to Reach US$23.8 Billion by 2030
The global market for Healthcare Cold Chain Logistics estimated at US$18.2 Billion in the year 2023, is expected to reach US$23.8 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Vaccines, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Clinical Trial Materials segment is estimated at 4.1% CAGR over the analysis period.
The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 6.0% CAGR
The Healthcare Cold Chain Logistics market in the U.S. is estimated at US$4.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.
Global Healthcare Cold Chain Logistics Market - Key Trends and Drivers Summarized
Why Is Healthcare Cold Chain Logistics Becoming Essential for Preserving the Integrity of Temperature-Sensitive Products and Ensuring Patient Safety?
Healthcare cold chain logistics has become essential for preserving the integrity of temperature-sensitive medical products, such as vaccines, biologics, and pharmaceuticals, while ensuring patient safety. But why is cold chain logistics so critical in healthcare today? Many medical products, especially those related to vaccines, blood products, and gene therapies, are highly sensitive to temperature fluctuations. Any deviation from the required storage conditions can degrade the product’s efficacy, render it unsafe for use, or lead to spoilage, which could result in adverse patient outcomes or substantial financial losses. Maintaining the correct temperature throughout the entire supply chain—from manufacturing facilities to the point of administration—is crucial to ensuring that these products remain effective and safe for patients.
Healthcare cold chain logistics involves specialized processes, packaging, monitoring, and transportation solutions to ensure that medical products are stored and distributed within a specific temperature range. This cold chain is necessary for maintaining the stability and potency of many life-saving products, especially those used in immunizations, cancer treatments, and other advanced medical therapies. With the increase in demand for biologics, personalized medicines, and vaccines, cold chain logistics is becoming increasingly critical in the healthcare industry, ensuring that patients receive products in their intended condition, with full therapeutic efficacy.
How Are Technological Advancements and Innovations Improving the Efficiency, Accuracy, and Monitoring of Healthcare Cold Chain Logistics?
Technological advancements are significantly improving the efficiency, accuracy, and monitoring of healthcare cold chain logistics, making it easier to manage the transportation and storage of temperature-sensitive medical products. One of the most impactful innovations is the use of real-time temperature monitoring systems. These systems employ sensors, GPS, and wireless communication to continuously track the temperature of medical products throughout the supply chain. If a product is exposed to temperatures outside its required range, the system sends an instant alert, allowing for immediate corrective actions to prevent product degradation. This real-time visibility enhances the reliability of cold chain logistics and reduces the risk of product loss.
Another key advancement is the development of smart packaging solutions, which are designed to maintain specific temperature ranges for extended periods. These packaging solutions often incorporate phase-change materials, vacuum insulation panels, and other advanced materials to protect products from temperature fluctuations. Some smart packages are equipped with data loggers that monitor and record temperature data, providing verifiable proof that the product has remained within the required conditions throughout its journey. This is particularly important for regulatory compliance, as healthcare products must meet strict guidelines for temperature control to ensure their safety and effectiveness.
Blockchain technology is also emerging as a transformative tool for improving the transparency and security of healthcare cold chain logistics. Blockchain enables the creation of a decentralized, tamper-proof ledger that records every transaction and movement of a product through the supply chain. This technology ensures that all parties involved in the supply chain—manufacturers, distributors, logistics providers, and healthcare facilities—have access to the same accurate information regarding the product’s temperature history, location, and handling. Blockchain’s transparency reduces the risk of fraud, ensures regulatory compliance, and improves trust between stakeholders by providing a verifiable chain of custody for temperature-sensitive products.
Artificial intelligence (AI) and machine learning (ML) are also playing a growing role in optimizing cold chain logistics. AI-powered systems can analyze large volumes of data related to temperature control, transportation routes, and storage conditions to identify inefficiencies and predict potential issues. For example, AI can forecast weather conditions, traffic delays, or equipment failures that might impact the cold chain and recommend alternative routes or solutions to mitigate risks. Machine learning algorithms continuously improve the accuracy of these predictions by learning from historical data, allowing logistics providers to make more informed decisions and enhance the reliability of cold chain processes.
The adoption of Internet of Things (IoT) devices in cold chain logistics is another significant innovation. IoT-enabled sensors can be placed in shipping containers, trucks, and storage facilities to monitor temperature, humidity, and other environmental factors in real time. These devices provide healthcare providers with continuous visibility into the condition of their products, allowing them to ensure that critical medicines, vaccines, or biological samples are stored within the correct temperature range. IoT solutions also allow for predictive maintenance of refrigeration equipment, reducing the risk of equipment failure and ensuring that products remain safe throughout the supply chain.
Why Is Healthcare Cold Chain Logistics Critical for Maintaining Product Efficacy, Reducing Waste, and Meeting Regulatory Requirements?
Healthcare cold chain logistics is critical for maintaining product efficacy, reducing waste, and meeting regulatory requirements because it ensures that temperature-sensitive medical products are stored and transported under optimal conditions. One of the main reasons cold chain logistics is so valuable is its role in preserving the efficacy of pharmaceuticals, vaccines, and biologics, many of which are sensitive to temperature fluctuations. For example, vaccines must be stored at specific temperatures to remain effective. If they are exposed to temperatures outside their recommended range, they may lose potency, putting patients at risk of receiving ineffective treatments. Cold chain logistics ensures that these products maintain their therapeutic integrity from the point of manufacture to the point of administration.
Reducing waste is another critical benefit of healthcare cold chain logistics. The improper handling or storage of temperature-sensitive products can lead to significant financial losses due to product spoilage. In some cases, entire shipments of vaccines or biologics may need to be discarded if there is evidence that they were exposed to temperature excursions. Effective cold chain management minimizes the risk of such incidents by providing real-time monitoring, predictive analytics, and automated alerts that allow for immediate corrective actions when deviations occur. This reduces product waste and helps healthcare organizations avoid the financial and operational consequences of losing valuable medical products.
Cold chain logistics is also essential for meeting regulatory requirements. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO) have established strict guidelines for the handling, storage, and transportation of temperature-sensitive medical products. These regulations ensure that healthcare providers adhere to best practices for maintaining product safety and efficacy. Failure to comply with these regulations can result in fines, penalties, or product recalls. Cold chain logistics systems, equipped with temperature monitoring and data logging technologies, help healthcare organizations meet these regulatory requirements by providing verifiable records of temperature control throughout the supply chain. These records are often required during audits and inspections to demonstrate compliance with national and international standards.
Healthcare cold chain logistics also plays a critical role in ensuring patient safety. When the integrity of temperature-sensitive products is compromised, patients may be exposed to suboptimal or unsafe treatments. For example, spoiled vaccines may fail to protect individuals from infectious diseases, while degraded biologics may lead to adverse reactions or ineffective therapies. By maintaining strict control over temperature conditions, cold chain logistics systems protect patients from these risks, ensuring that they receive high-quality, effective treatments that meet safety standards. This is particularly important in areas like cancer treatment, where biologics and gene therapies are essential for patient care and must be handled with extreme care.
Another benefit of cold chain logistics is its ability to support global healthcare efforts, particularly in remote or underserved regions. Many life-saving vaccines and medicines must be transported across long distances to reach areas with limited healthcare infrastructure. Cold chain logistics ensures that these products can safely reach their destination without degradation, enabling healthcare providers to administer them effectively. This is especially crucial during global vaccination campaigns or responses to public health emergencies, where maintaining the cold chain is essential for the success of healthcare interventions.
What Factors Are Driving the Growth of the Healthcare Cold Chain Logistics Market?
Several key factors are driving the rapid growth of the healthcare cold chain logistics market, including the increasing demand for biologics and personalized medicines, the rise of global vaccination campaigns, advancements in cold chain technologies, and the expansion of pharmaceutical supply chains into emerging markets. One of the primary drivers is the growing demand for biologics and personalized medicines, which are highly sensitive to temperature variations and require precise storage conditions. Biologics, such as monoclonal antibodies, cell therapies, and gene therapies, represent a significant portion of new drug approvals, and their use is expected to continue rising. The need for specialized cold chain logistics to transport and store these products is fueling the growth of the market.
The rise of global vaccination campaigns is another significant factor contributing to the expansion of healthcare cold chain logistics. The COVID-19 pandemic highlighted the importance of an efficient and reliable cold chain for distributing vaccines on a global scale. Many COVID-19 vaccines, including mRNA vaccines, require ultra-low temperature storage, making cold chain logistics essential for their safe distribution. As global health organizations and governments continue to implement large-scale vaccination campaigns, the demand for cold chain logistics solutions that can ensure the safe transport of vaccines to all parts of the world, including remote regions, is expected to grow.
Advancements in cold chain technologies, such as real-time monitoring systems, smart packaging, and IoT-enabled sensors, are also driving the growth of the market. These innovations make it easier for healthcare providers to track and maintain temperature-sensitive products throughout the supply chain. Real-time data logging and alerts enable organizations to quickly address any issues that arise during transportation or storage, reducing the risk of product spoilage. The growing adoption of these advanced technologies is improving the efficiency and reliability of cold chain logistics, making it an increasingly attractive solution for pharmaceutical companies and healthcare organizations.
The expansion of pharmaceutical supply chains into emerging markets is another key driver of growth in the healthcare cold chain logistics sector. As pharmaceutical companies seek to reach new markets in developing regions, they face the challenge of transporting temperature-sensitive products across long distances, often through regions with inadequate infrastructure. Cold chain logistics providers are expanding their networks and capabilities to ensure that these products can reach their destination without compromising quality or safety. The demand for cold chain solutions that can navigate complex international logistics environments is expected to increase as pharmaceutical companies continue to grow their presence in emerging markets.
Regulatory pressure is also contributing to the growth of the healthcare cold chain logistics market. As regulatory agencies around the world tighten guidelines for the storage and transportation of temperature-sensitive products, healthcare organizations must invest in cold chain systems that can meet these stringent requirements. Regulatory compliance is essential not only for ensuring patient safety but also for avoiding fines, penalties, or product recalls. The need to comply with evolving regulations is prompting healthcare providers and pharmaceutical companies to adopt more advanced and reliable cold chain logistics solutions.
In conclusion, the growth of the healthcare cold chain logistics market is driven by increasing demand for biologics, global vaccination campaigns, advancements in cold chain technologies, and the expansion of pharmaceutical supply chains into emerging markets. As healthcare organizations face the growing challenge of maintaining the integrity of temperature-sensitive products, cold chain logistics will play an essential role in ensuring product safety, regulatory compliance, and effective patient care.
Select Competitors (Total 44 Featured) -
American Airlines, Inc.
AmerisourceBergen Corporation
Cavalier Logistics
Continental Carbon Company
DB Schenker
DHL International GmbH
FedEx Corporation
Kuehne + Nagel International AG
Marken Ltd.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Healthcare Cold Chain Logistics - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Demand for Temperature-sensitive Pharmaceuticals Drives Growth in Healthcare Cold Chain Logistics
Expansion of Biologics, Vaccines, and Biosimilars Fuels Demand for Cold Chain Solutions
Role of Cold Chain Logistics in Ensuring Drug Safety and Efficacy Throughout Distribution
Technological Advancements in IoT and Sensor-based Monitoring Enhance Cold Chain Logistics
Role of Cold Chain Logistics in Reducing Pharmaceutical Waste and Expiry
Expansion of Cold Chain Infrastructure in Emerging Markets to Support Global Vaccine Distribution
Role of Blockchain in Enhancing Transparency and Traceability in Healthcare Cold Chain Logistics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Healthcare Cold Chain Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Clinical Trial Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
JAPAN
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
CHINA
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
EUROPE
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
FRANCE
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
GERMANY
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
UNITED KINGDOM
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
SPAIN
TABLE 80: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 83: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
RUSSIA
TABLE 86: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 89: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
AUSTRALIA
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 107: Australia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 110: Australia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
INDIA
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 113: India Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 116: India Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 119: South Korea Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 122: South Korea Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
LATIN AMERICA
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 131: Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 140: Argentina Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 143: Argentina Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
BRAZIL
TABLE 146: Brazil Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 149: Brazil Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
MEXICO
TABLE 152: Mexico Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 155: Mexico Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
MIDDLE EAST
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 164: Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
IRAN
TABLE 173: Iran Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 176: Iran Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
ISRAEL
TABLE 179: Israel Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 182: Israel Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 191: UAE Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 194: UAE Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
AFRICA
Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 203: Africa Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2014, 2024 & 2030
TABLE 206: Africa Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2014, 2024 & 2030
